These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 34977959)
1. Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials. Llanaj E; Dejanovic GM; Valido E; Bano A; Gamba M; Kastrati L; Minder B; Stojic S; Voortman T; Marques-Vidal P; Stoyanov J; Metzger B; Glisic M; Kern H; Muka T Eur J Nutr; 2022 Jun; 61(4):1749-1778. PubMed ID: 34977959 [TBL] [Abstract][Full Text] [Related]
2. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Ho HV; Sievenpiper JL; Zurbau A; Blanco Mejia S; Jovanovski E; Au-Yeung F; Jenkins AL; Vuksan V Br J Nutr; 2016 Oct; 116(8):1369-1382. PubMed ID: 27724985 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Yu J; Xia J; Yang C; Pan D; Xu D; Sun G; Xia H Nutrients; 2022 May; 14(10):. PubMed ID: 35631184 [TBL] [Abstract][Full Text] [Related]
6. Dietary fibre for the primary prevention of cardiovascular disease. Hartley L; May MD; Loveman E; Colquitt JL; Rees K Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011472. PubMed ID: 26758499 [TBL] [Abstract][Full Text] [Related]
7. Effects of high-quality protein supplementation on cardiovascular risk factors in individuals with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Zhou S; Cheng F; He J; Xu T; Zhang X; Wan S; Qi J; He J; Chen F; Luo J; Luo Y; An P Clin Nutr; 2024 Aug; 43(8):1740-1750. PubMed ID: 38924998 [TBL] [Abstract][Full Text] [Related]
8. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease. Flowers N; Hartley L; Todkill D; Stranges S; Rees K Cochrane Database Syst Rev; 2014; 2014(12):CD010405. PubMed ID: 25474484 [TBL] [Abstract][Full Text] [Related]
9. Vegan dietary pattern for the primary and secondary prevention of cardiovascular diseases. Rees K; Al-Khudairy L; Takeda A; Stranges S Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013501. PubMed ID: 33629376 [TBL] [Abstract][Full Text] [Related]
10. The separate effects of whole oats and isolated beta-glucan on lipid profile: A systematic review and meta-analysis of randomized controlled trials. de Morais Junior AC; Schincaglia RM; Viana RB; Armet AM; Prado CM; Walter J; Mota JF Clin Nutr ESPEN; 2023 Feb; 53():224-237. PubMed ID: 36657917 [TBL] [Abstract][Full Text] [Related]
11. Narrative Review on the Effects of Oat and Sprouted Oat Components on Blood Pressure. Liska DJ; Dioum E; Chu Y; Mah E Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432463 [TBL] [Abstract][Full Text] [Related]
12. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease. Rees K; Takeda A; Martin N; Ellis L; Wijesekara D; Vepa A; Das A; Hartley L; Stranges S Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009825. PubMed ID: 30864165 [TBL] [Abstract][Full Text] [Related]
13. Effects of Dairy Intake on Markers of Cardiometabolic Health in Adults: A Systematic Review with Network Meta-Analysis. Kiesswetter E; Stadelmaier J; Petropoulou M; Morze J; Grummich K; Roux I; Lay R; Himmelsbach L; Kussmann M; Roeger C; Rubach M; Hauner H; Schwingshackl L Adv Nutr; 2023 May; 14(3):438-450. PubMed ID: 36914032 [TBL] [Abstract][Full Text] [Related]
14. Omega-6 fats for the primary and secondary prevention of cardiovascular disease. Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011094. PubMed ID: 30019765 [TBL] [Abstract][Full Text] [Related]
15. Omega-6 fats for the primary and secondary prevention of cardiovascular disease. Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011094. PubMed ID: 30488422 [TBL] [Abstract][Full Text] [Related]
16. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials. Whitehead A; Beck EJ; Tosh S; Wolever TM Am J Clin Nutr; 2014 Dec; 100(6):1413-21. PubMed ID: 25411276 [TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of the effects of beta-glucan consumption on serum lipid profile and glucose level in hypercholesterolemic subjects. Zhu X; Sun X; Wang M; Zhang C; Cao Y; Mo G; Liang J; Zhu S Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):714-23. PubMed ID: 26026211 [TBL] [Abstract][Full Text] [Related]
18. Interventions for weight loss in people with chronic kidney disease who are overweight or obese. Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of oats in dyslipidemia: a systematic review and meta-analysis. Li A; Gao J; Li Y; Qi S; Meng T; Yu S; Zhang Y; He Q Food Funct; 2024 Apr; 15(7):3232-3245. PubMed ID: 38441173 [No Abstract] [Full Text] [Related]